The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European…
By L. Anderson, D. Pennell. European Heart Journal, 2008
886 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Infectious Diseases, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/afb4d96d38087cbbaa52eb71078c2e575d19ad0c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- T. Horwich
- Jeroen J. Bax
- Helmut Baumgartner
- Paulus Kirchhof
- Gerasimos Filippatos
- Frank Flachskampf
- Volkmar Falk
Citations in the corpus
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “Additional other indications for endomyocardial biopsy include in patients with rapidly progressive and unexplained cardiomyopathy, those in whom active myocarditis, especially giant cell myocarditis, is being considered (310).”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “Page 16 rate per 1,000 person-years was lowest among white women (52, 53) and highest among black men (57), with”
- Dilated Cardiomyopathy (2007, background): “The American College of Cardiology/American Heart Association guidelines recommend EMB in patients with severe clinical presentation in terms of recent heart failure or lifethreatening arrhythmias [10, 12].”
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. (2018, methodology): “According to the recommendations of the American Heart Association, the American College of Cardiology, and the ESC, the indication for EMB should be considered for patients with acute (<2 weeks), severe new onset heart failure with hemodynamic compromise, as well as new onset heart failure (between”
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2012, methodology): “The use of this procedure is described in detail in other guidelines.(72) Table 9 Common echocardiographic measures of left ventricular diastolic dysfunction in patients with heart failure”
- Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment (2011, background): “continued, especially if the patient has received high doses of the agent [78].”